As we move further along into 2019, the stage is set for what I expect to be a critical year in the trajectory of New Jersey’s cannabis sector. While specifics remain to be seen, there is little doubt that it will continue to flourish – whether through the passage of recreational legislation, a further expansion
Department of Health
One-on-One with Cresco Labs’ Jason Erkes
By Lee Vartan on
Inspired by the NJ Cannabis Insider Q&A with Satya Capital’s Nishant Reddy, I sat with Jason Erkes, Chief Communications Officer with Cresco Labs, for a closer look at the company’s New Jersey plans.
One of the fastest-growing companies in the cannabis space, Cresco was supported by CSG’s Cannabis Law Group on its application…
CSG client, Satya Capital, featured in Q&A with NJ Cannabis Insider
By Lee Vartan on
I am pleased to share with our subscribers an NJ Cannabis Insider Q&A featuring Nishant Reddy, co-founder of the California-based boutique investment firm Satya Capital. CSG supported Satya as they partnered with MedMen on a joint application to operate a medicinal marijuana dispensary in Newark, NJ as part of the New Jersey Department of …
New Jersey Issues RFA for Six New Medical Marijuana Dispensaries
On July 16, 2018, the New Jersey Department of Health’s Division of Medicinal Marijuana (the “DOH”) issued a Request for Applications (“RFA”) for up to six additional Alternative Treatment Centers (“ATCs”), commonly referred to as medical marijuana dispensaries. The DOH will award two licenses in the northern region of the state, two in the central…
NJ Department of Health Publishes Proposed Amendments to Medical Marijuana Program
On June 18, 2018, the New Jersey Department of Health (the “DOH”) published for comment its proposed amendments to the administrative regulations to New Jersey’s Medical Marijuana Program (“MMP”). These regulations establish the standards by which the DOH implements the Compassionate Use Medical Marijuana Act, codified at N.J.S.A. 24:6I-1 et. seq.
The proposed regulatory amendments…